Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 17 of 17 entries
Sorted by: Best Match Show Resources per page
Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on "Internal and External Relieving -Truncated Torsion" strategy.

Medicine

Wu X, Lu W, Guo Q, Cao M, Zhang W, Liu C, Qu Y, Peng W, Che J, Fang B, Zhou S.
PMID: 33371175
Medicine (Baltimore). 2020 Dec 18;99(51):e23874. doi: 10.1097/MD.0000000000023874.

INTRODUCTION: The outbreak of novel coronavirus disease 2019 (COVID-19) has caused a global pandemic since December 2020. It has not only associated with physiological disorder but also with psychological distress and symptoms of mental illness. Whether the vaccines and...

Cite
Wu X, Lu W, Guo Q, et al. Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on "Internal and External Relieving -Truncated Torsion" strategy. Medicine (Baltimore). 2020;99(51):e23874doi: 10.1097/MD.0000000000023874.
Wu, X., Lu, W., Guo, Q., Cao, M., Zhang, W., Liu, C., Qu, Y., Peng, W., Che, J., Fang, B., & Zhou, S. (2020). Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on "Internal and External Relieving -Truncated Torsion" strategy. Medicine, 99(51), e23874. https://doi.org/10.1097/MD.0000000000023874
Wu, Xinxin, et al. "Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on "Internal and External Relieving -Truncated Torsion" strategy." Medicine vol. 99,51 (2020): e23874. doi: https://doi.org/10.1097/MD.0000000000023874
Wu X, Lu W, Guo Q, Cao M, Zhang W, Liu C, Qu Y, Peng W, Che J, Fang B, Zhou S. Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on "Internal and External Relieving -Truncated Torsion" strategy. Medicine (Baltimore). 2020 Dec 18;99(51):e23874. doi: 10.1097/MD.0000000000023874. PMID: 33371175; PMCID: PMC7748371.
Copy Download .nbib Format: NLM
Chinese Herbal Medicine for Weight Management: A Systematic Review and Meta-Analyses of Randomised Controlled Trials.

Journal of obesity

Wong AR, Yang AWH, Li K, Gill H, Li M, Lenon GB.
PMID: 33763238
J Obes. 2021 Mar 09;2021:3250723. doi: 10.1155/2021/3250723. eCollection 2021.

OBJECTIVE: This review investigated the effects and safety of Chinese herbal medicine (CHM) formulas on weight management.METHODS: Eighteen databases in English, Chinese, Korean, and Japanese were searched from their inceptions to September 2019. The treatment groups included CHM formulations,...

Cite
Wong AR, Yang AWH, Li K, et al. Chinese Herbal Medicine for Weight Management: A Systematic Review and Meta-Analyses of Randomised Controlled Trials. J Obes. 2021;2021:3250723doi: 10.1155/2021/3250723.
Wong, A. R., Yang, A. W. H., Li, K., Gill, H., Li, M., & Lenon, G. B. (2021). Chinese Herbal Medicine for Weight Management: A Systematic Review and Meta-Analyses of Randomised Controlled Trials. Journal of obesity, 20213250723. https://doi.org/10.1155/2021/3250723
Wong, Ann Rann, et al. "Chinese Herbal Medicine for Weight Management: A Systematic Review and Meta-Analyses of Randomised Controlled Trials." Journal of obesity vol. 2021 (2021): 3250723. doi: https://doi.org/10.1155/2021/3250723
Wong AR, Yang AWH, Li K, Gill H, Li M, Lenon GB. Chinese Herbal Medicine for Weight Management: A Systematic Review and Meta-Analyses of Randomised Controlled Trials. J Obes. 2021 Mar 09;2021:3250723. doi: 10.1155/2021/3250723. eCollection 2021. PMID: 33763238; PMCID: PMC7964117.
Copy Download .nbib Format: NLM
Issues for the FDA.

Lancet (London, England)

Xue T.
PMID: 7491016
Lancet. 1995 Dec 02;346(8988):1492.

No abstract available.

Cite
Xue T. Issues for the FDA. Lancet. 1995;346(8988):1492
Xue, T. (1995). Issues for the FDA. Lancet (London, England), 346(8988), 1492.
Xue, T. "Issues for the FDA." Lancet (London, England) vol. 346,8988 (1995): 1492.
Xue T. Issues for the FDA. Lancet. 1995 Dec 02;346(8988):1492. PMID: 7491016.
Copy Download .nbib Format: NLM
Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease.

Chinese journal of integrative medicine

Sheng S, Yang ZX, Xu FQ, Huang Y.
PMID: 32388823
Chin J Integr Med. 2021 Feb;27(2):106-114. doi: 10.1007/s11655-020-3199-z. Epub 2020 May 09.

OBJECTIVE: To study the pharmacological mechanism of Guanxin II formula (II) for treatment of coronary heart disease (CHD).METHODS: A network pharmacology-based method was utilized. First candidate compounds, targets of GX II were collected using PharmMapper, BATMAN-TCM, DrugBank and SwissTargetPrediction,...

Cite
Sheng S, Yang ZX, Xu FQ, et al. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease. Chin J Integr Med. 2020;27(2):106-114doi: 10.1007/s11655-020-3199-z.
Sheng, S., Yang, Z. X., Xu, F. Q., & Huang, Y. (2021). Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease. Chinese journal of integrative medicine, 27(2), 106-114. https://doi.org/10.1007/s11655-020-3199-z
Sheng, Song, et al. "Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease." Chinese journal of integrative medicine vol. 27,2 (2021): 106-114. doi: https://doi.org/10.1007/s11655-020-3199-z
Sheng S, Yang ZX, Xu FQ, Huang Y. Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin II Formula (II) for Coronary Heart Disease. Chin J Integr Med. 2021 Feb;27(2):106-114. doi: 10.1007/s11655-020-3199-z. Epub 2020 May 09. PMID: 32388823.
Copy Download .nbib Format: NLM
Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer.

Journal of global oncology

White JD, Lin H, Jia L, Wu RS, Lam S, Li J, Dou J, Kumar N, Lin L, Lao L.
PMID: 29244995
J Glob Oncol. 2017 Dec;3(6):814-822. doi: 10.1200/JGO.2016.005710. Epub 2016 Oct 28.

On November 3, 2014, in Bethesda, MD, the Office of Cancer Complementary and Alternative Medicine of the National Cancer Institute held a meeting to examine the potential utility and feasibility of establishing an international consortium for Chinese medicine and...

Cite
White JD, Lin H, Jia L, et al. Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer. J Glob Oncol. 2016;3(6):814-822doi: 10.1200/JGO.2016.005710.
White, J. D., Lin, H., Jia, L., Wu, R. S., Lam, S., Li, J., Dou, J., Kumar, N., Lin, L., & Lao, L. (2017). Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer. Journal of global oncology, 3(6), 814-822. https://doi.org/10.1200/JGO.2016.005710
White, Jeffrey D, et al. "Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer." Journal of global oncology vol. 3,6 (2017): 814-822. doi: https://doi.org/10.1200/JGO.2016.005710
White JD, Lin H, Jia L, Wu RS, Lam S, Li J, Dou J, Kumar N, Lin L, Lao L. Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and Cancer. J Glob Oncol. 2017 Dec;3(6):814-822. doi: 10.1200/JGO.2016.005710. Epub 2016 Oct 28. PMID: 29244995; PMCID: PMC5735960.
Copy Download .nbib Format: NLM
Showing 13 to 17 of 17 entries